会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • SYSTEM AND METHOD FOR DE-EMBEDDING A DEVICE UNDER TEST EMPLOYING A PARAMETRIZED NETLIST
    • 在使用参数化列表的测试中去除嵌入式设备的系统和方法
    • US20090224772A1
    • 2009-09-10
    • US12043169
    • 2008-03-06
    • Basanth JagannathanZhenrong JinHongmei Li
    • Basanth JagannathanZhenrong JinHongmei Li
    • G01R35/00
    • G01R27/32G01R35/00
    • S-parameter data is measured on an embedded device test structure, an open dummy, and a short dummy. A 4-port network of the pad set parasitics of the embedded device test structure is modeled by a parameterized netlist containing a lumped element network having at least one parameterized lumped element. The S-parameter data across a range of measurement frequencies is fitted with the parametrized netlist employing the at least one parameterized lumped element as at least one fitting parameter for the S-parameter data. Thus, the fitting method is a multi-frequency fitting for the at least one parameterized lumped element. A 4-port Y-parameter (admittance parameter) is obtained from the fitted parameterized netlist. The Y-parameter of the device under test is obtained from the measured admittance of the embedded device test structure and the calculated 4-port Y parameter.
    • S参数数据是在嵌入式设备测试结构上测量的,一个开放虚拟的和一个短虚拟的。 嵌入式设备测试结构的焊盘组寄生效应的4端口网络由包含具有至少一个参数化集总元件的集总元件网络的参数化网表建模。 将测量频率范围内的S参数数据与采用至少一个参数化集总元件的参数化网表拟合为S参数数据的至少一个拟合参数。 因此,拟合方法是用于至少一个参数化的集总元件的多频率拟合。 从拟合的参数化网表获得4端口Y参数(导纳参数)。 被测器件的Y参数是从嵌入式器件测试结构的测量导纳和计算的4端口Y参数获得的。
    • 23. 发明申请
    • Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
    • 取代的N-芳基磺酰基杂环胺作为γ-分泌酶抑制剂
    • US20060040936A1
    • 2006-02-23
    • US11168797
    • 2005-06-28
    • Hubert JosienJohn CladerThomas BaraRuo XuHongmei LiDmitri PissarnitskiZhiqiang Zhao
    • Hubert JosienJohn CladerThomas BaraRuo XuHongmei LiDmitri PissarnitskiZhiqiang Zhao
    • A61K31/5377A61K31/498A61K31/496A61K31/46C07D43/02C07D413/02C07D487/04
    • C07D265/30C07D413/12C07D451/02C07D487/08
    • This invention discloses novel gamma secretase inhibitors of the formula: wherein: L is —O—, —N(R6)—, —S—, —S(O)—, or —S(O2)—; R1 is selected from the group consisting of aryl and heteroaryl; R2 is selected from the group consisting of alkyl, —C(O)—Y, —X—C(O)—Y, -alkylene-X—C(O)—Y, -alkylene-C(O)—Y, -alkylene-cycloalkylene-X—C(O)—Y, -alkylene-cycloalkylene-C(O)—Y, -cycloalkylene-alkylene-X—C(O)—Y, -cycloalkylene-alkylene-C(O)—Y, -cycloalkylene-X—C(O)—Y, -cycloalkylene-C(O)—Y, -alkylene-cycloalkylene-alkylene-X—C(O)—Y, -alkylene-cycloalkylene-alkylene-C(O)—Y, aryl, and heteroaryl; R3 is selected from the group consisting of aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, and alkoxyalkyl; each R4 and R5 is independently selected from the group consisting of H and alkyl; and Y is selected from the group consisting of —NR8R9, —N(R6)—(CH2)b—NR8R9, aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, and arylheterocycloalkyl; or Y is selected from the group consisting of: One or more compounds of formula I, or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.
    • 本发明公开了下式的新型γ分泌酶抑制剂:其中:L是-O-,-N(R 6) - , - S - , - S(O) - 或-S(O - ; R 1选自芳基和杂芳基; R 2选自烷基,-C(O)-Y,-XC(O)-Y, - 亚烷基-XC(O)-Y, - 亚烷基-C(O )-Y-亚烷基 - 亚环烷基-OC(O)-Y-亚烷基 - 亚环烷基-C(O)-Y-亚烷基 - 亚烷基-OC(O)-Y-亚烷基 - 亚烷基-C(O) Y( - )亚环烷基-C(O)-Y-亚烷基-C(O)-Y-亚烷基 - 亚环烷基亚烷基-XC(O)-Y-亚烷基 - 亚环烷基 - 亚烷基-C(O)-Y, 芳基和杂芳基; R 3选自芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基,芳基杂环烷基和烷氧基烷基; 每个R 4和R 5独立地选自H和烷基; 并且Y选自-NR 8 R 9,-N(R 6) - (CH 2) 芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基和芳基杂环烷基 ; 或Y选自:一种或多种式I化合物或包含该化合物的制剂可用于,例如, 治疗阿尔茨海默病。
    • 30. 发明申请
    • Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors
    • 取代的N-芳基磺酰基杂环胺作为γ-分泌酶抑制剂
    • US20100087425A1
    • 2010-04-08
    • US12633286
    • 2009-12-08
    • Hubert B. JosienJohn W. CladerThomas A. BaraRuo XuHongmei LiDmitri A. PissarnitakiZhiqiang Zhao
    • Hubert B. JosienJohn W. CladerThomas A. BaraRuo XuHongmei LiDmitri A. PissarnitakiZhiqiang Zhao
    • A61K31/5377C07D413/14C07D413/12C07D417/12C07D417/14A61K31/541A61P25/00A61P25/28
    • C07D265/30C07D413/12C07D451/02C07D487/08
    • This invention discloses novel gamma secretase inhibitors of the formula: wherein: L is —O—, —N(R6)—, —S—, —S(O)—, or —S(O2)—; R1 is selected from the group consisting of aryl and heteroaryl; R2 is selected from the group consisting of alkyl, —C(O)—Y, —X—C(O)—Y, -alkylene-X—C(O)—Y, -alkylene-C(O)—Y, -alkylene-cycloalkylene-X—C(O)—Y, -alkylene-cycloalkylene-C(O)—Y, -cycloalkylene-alkylene-X—C(O)—Y, -cycloalkylene-alkylene-C(O)—Y, -cycloalkylene-X—C(O)—Y, -cycloalkylene-C(O)—Y, -alkylene-cycloalkylene-alkylene-X—C(O)—Y, -alkylene-cycloalkylene-alkylene-C(O)—Y, aryl, and heteroaryl; R3 is selected from the group consisting of aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, and alkoxyalkyl; each R4 and R5 is independently selected from the group consisting of H and alkyl; and Y is selected from the group consisting of —NR8R9, —N(R6)—(CH2)b—NR8R9, aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, and aryl heterocycloalkyl; or Y is selected from the group consisting of: One or more compounds of formula I, or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.
    • 本发明公开了下式的新型γ-分泌酶抑制剂:其中:L是-O - , - N(R6) - , - S - , - S(O) - 或-S(O 2) - ; R 1选自芳基和杂芳基; R 2选自烷基,-C(O)-Y,-X-C(O)-Y, - 亚烷基-X-C(O)-Y, - 亚烷基-C(O)-Y, - 亚烷基 - 亚环烷基-X-C(O)-Y-亚烷基 - 亚环烷基-C(O)-Y-亚烷基 - 亚烷基-X-C(O)-Y-亚烷基 - 亚烷基-C(O) (O)-Y-亚烷基-C(O)-Y-亚烷基 - 亚环烷基 - 亚烷基-X-C(O)-Y-亚烷基 - 亚环烷基 - 亚烷基-C(O )-Y,芳基和杂芳基; R 3选自芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基,芳基杂环烷基和烷氧基烷基; 每个R 4和R 5独立地选自H和烷基; 并且Y选自-NR8R9,-N(R6) - (CH2)b-NR8R9,芳基,杂芳基,烷基,环烷基,芳基烷基,芳基环烷基,杂芳基烷基,杂芳基环烷基和芳基杂环烷基; 或Y选自:一种或多种式I化合物或包含该化合物的制剂可用于,例如, 治疗阿尔茨海默病。